🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Catherine Diefenbach

Columbia University Irving Medical Center

ORCID: 0000-0003-1116-3246

Also affiliated with NYU Langone Health, New York Oncology Hematology, New York University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial”.

Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30221-0

N/A

3.3DataRank · unranked

142 citations

Fangxin Hong, Richard F. Ambinder, Jonathon B. Cohen, Michael J. Robertson, Kevin A. David +12 more

Distinct autoantibody profiles across checkpoint inhibitor types and toxicities

OncoImmunology(2024)10.1080/2162402x.2024.2351255

N/A

0.560DataRank · unranked

10 citations

Mitchell S. von Itzstein, Farjana Fattah, Jialiang Liu, Chengsong Zhu, Yang Xie +6 more

Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients

medRxiv(2021)10.1101/2021.06.02.21257804

N/A

0.483DataRank · unranked

24 citations

Jessica Caro, Akiko Koide, Michael L. Grossbard, Judith D. Goldberg, Bruce G. Raphael +10 more

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies

Blood Advances(2024)10.1182/bloodadvances.2024014633

N/A

0.420DataRank · unranked

9 citations

Danielle M. Brander, Yesid Alvarado, Catherine Diefenbach, Daniel Nathan Egan, Shira Dinner +14 more

Results of the DIAL study (NCI 10089), a randomized phase 2 trial of varlilumab combined with nivolumab in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (r/r B-NHL).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.17_suppl.lba7564

N/A

0.208DataRank · unranked

3 citations

Justin Kline, Aleksandr Lazaryan, Nancy L. Bartlett, Francisco J. Hernandez‐Ilizaliturri, Farrukh T. Awan +13 more

Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0252

N/A

0.208DataRank · unranked

3 citations

Hsin-Hui Huang, Opeyemi A. Jagede, Kevin Tuballes, Diane M. Del Valle, Geoffrey Kelly +19 more

A randomized controlled trial of postbiotic administration during antibiotic treatment increases microbiome diversity and enriches health associated taxa

medRxiv(2024)10.1101/2024.07.25.24311015

N/A

0DataRank · unranked

1 citations

Fanny Matheis, Wataru Ebina, William Jogia, Alexis Sullivan, Kelly Gordon +9 more

Epstein-Barr Virus-Positive Primary Central Nervous System Lymphoma in a 40-Year-Old Immunocompetent Patient

Cureus(2021)10.7759/cureus.12754

N/A

0DataRank · unranked

10 citations

Liu C, Catherine Diefenbach, Dimitris G. Placantonakis, Sabastian Hajtovic

A retrospectively registered pilot randomized controlled trial of postbiotic administration during antibiotic treatment increases microbiome diversity and enriches health-associated taxa

Infection and Immunity(2025)10.1128/iai.00390-25

N/A

0DataRank · unranked

2 citations

William Jogia, Fanny Matheis, Wataru Ebina, Alexis Sullivan, Kelly Gordon +10 more

Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3261

N/A

0DataRank · unranked

30 citations

Manish R. Patel, John M. Burke, Ranjana H. Advani, Bruce D. Cheson, Jeff P. Sharman +11 more

Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study

Haematologica(2021)10.3324/haematol.2020.270876

N/A

0DataRank · unranked

42 citations

Andrew M. Evens, Alexey V. Danilov, Stephen D. Smith, Deepa Jagadeesh, Lori A. Leslie +52 more

Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas

British Journal of Haematology(2024)10.1111/bjh.19419

N/A

0DataRank · unranked

5 citations

Catherine Diefenbach, Deepa Jagadeesh, Adam Asch, Abhijeet Kumar, Michaela L. Tsai +11 more